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Hepatocytes derived from embryonic stem cells (ESCs) are a potential cell source for 
regenerative medicine. However, it has been technically difficult to differentiate ESCs 
into mature hepatocytes because the definitive growth factors and molecular 









 mesenchymal cells that reside in murine fetal livers induce 
hepatic progenitor cells to differentiate into mature hepatocytes by direct cell-cell 
contact. Utilizing these cells, we employ a two-step procedure for hepatic maturation of 
ESC: first, ESCs are differentiated into endodermal cells or hepatic progenitor cells, and 
second, ESC-derived endodermal cells are matured into functional hepatocytes by 
co-culture with the murine fetal liver mesenchymal cells. The ESC-derived 
hepatocyte-like cells possess hepatic functions, including the ammonia removal activity, 
albumin secretion ability, glycogen synthesis and storage, and cytochrome P450 
enzymatic activity. 
ii. Keywords: embryonic stem cell; fetal liver; hepatocyte; hepatic progenitor cell; 
mesenchymal cell; Thy1; gp38. 
1. Introduction 
Embryonic stem cells (ESCs) are established from inner cell masses and possess a 
pluripotency to differentiate into all three germ layers. Hepatocytes derived from ESCs 
are anticipated as a cell source for cell transplantation, bio-artificial livers, and drug 
discovery support systems. However, there have been difficulties differentiating ESCs 
into mature functional hepatocytes because the molecular mechanisms that underlie 
hepatic development are largely unknown. 
Our previous study revealed that the hepatic maturation of fetal hepatic progenitor cells 
is greatly facilitated by mesenchymal cells that reside in the fetal livers (1). These 








 cells (2). In addition, 
our further experiments demonstrated their ability to mature murine and human ESCs 









mesenchymal cells on hepatic maturation is achieved by direct cell-cell contact (5). 
They do not induce hepatic maturation of undifferentiated ESCs, suggesting that 
mesenchymal cells are effective in hepatic maturation of immature endodermal cells, 
but are relatively ineffective at hepatic specification and differentiation of 
undifferentiated ESCs (4). 
In this chapter, we describe a two-step procedure for the hepatic maturation of mouse 








 mesenchymal cells based on their 
biological characteristics. First, undifferentiated ESCs are differentiated into 
endodermal cells of the hepatic lineage using several growth factors and extracellular 
matrix. Second, the ESC-derived endodermal cells are matured into functional 












2.1. Culture of mouse ESCs 
1. A murine ESC line (see Note 1). 
2. ESC culture medium: Dulbecco's modified Eagle’s medium (DMEM) supplemented 
with 20% fetal bovine serum (FBS, HyClone, Logan, UT), 0.1 mM 2-mercaptoethanol, 
nonessential amino acids, 1 mM sodium pyruvate, and 1000 U/ml leukemia inhibitory 
factor (LIF, ESGRO, Chemicon International Inc., Temecula, CA) (see Note 2). A stock 
solution of 1 × 10
7 
U/ml LIF is stored at 4 ºC. 
3. A solution of 0.25% trypsin and 1 mM ethylenediaminetetraacetic acid (EDTA). 
4. 35 mm plastic culture dishes with a mouse embryonic fibroblast (MEF) feeder layer 
treated with 10g/ml mitomycin C for 2 hours (see Note 3). 
 
2.2. Differentiation of ESCs into endoderm 
1. Serum-free endoderm differentiation medium (SFE medium): DMEM supplemented 
with 10% Knockout SR (Gibco, Grand Island, NY), 2 mM L-glutamine, 1 mM sodium 
pyruvate, and penicillin/streptomycin (50 units/ml each). 
2. All-trans retinoic acid is dissolved at 10 mM in 99.5% ethanol, and stored in aliquots 
at −80 ºC. LIF is dissolved at 1 × 106 U/ml in a culture medium, and stored at 4 ºC. 
Basic fibroblast growth factor (bFGF) and hepatocyte growth factor (HGF) are 
dissolved to a concentration of 20 M in phosphate-buffered saline (PBS, Ca2+-free) 
supplemented with 0.5% bovine serum albumin (BSA), and stored in aliquots at −80 ºC. 
These growth factors are added to culture dishes as required (see Note 4). 
3. 60 mm culture dishes coated with type I collagen (pre-coated dishes purchased from 
BD Biosciences, Franklin Lakes, NJ). 
 
2.3. Primary culture of murine fetal liver cells 
1. A stereomicroscope system. 
2. A set of sterilized surgical instruments, including scissors, micro forceps, and a 
surgical knife. 
3. A pair of sterilized surgical gloves. 
4. Two pregnant C57/BL6 mice at day 13.5 of gestation (see Note 5). 




-free Hank's balanced salt solution with phenol red 
(HBSS (−)) with 10 mM HEPES and 0.5 mM EDTA. 
6. Irrigation solution 1 (50 ml): HBSS-based buffer (45 ml) supplemented with 10% 
FBS (5 ml), and 2 U/ml heparin sodium solution (0.1 ml). Heparin sodium solution at 
1000 U/ml is readily purchased from several pharmaceutical companies. This solution is 
prepared as required and kept at 4 ºC (see Note 6). 
7. Irrigation solution 2 (50 ml): HBSS-based buffer (45 ml) supplemented with 50 
mg/ml DNase I (1 ml of stock solution), and 2 U/ml heparin sodium (0.1 ml). DNase I 
is dissolved at 25 mg/ml in distilled water, and stored in single use aliquots at −20 ºC. 
This solution is prepared as required, and kept at 4 ºC (see Note 7). 
8. Digestion medium (30 ml): 0.5 % (w/v) collagenase type II (Gibco) is dissolved in 30 
ml collagenase buffer and 0.1 ml heparin sodium. This medium is kept at 37 ºC prior to 
use. Collagenase buffer contains 0.2 g MgSO4·7H2O, 0.735 g CaCl2·2H2O, 2.383 g 
HEPES, and 0.05 g trypsin inhibitor in 1 l HBSS (−). This buffer can be preserved at 4 
ºC for a month.  
9. Hepatocyte differentiation medium (HD medium): DMEM with 10% FBS, 1 mM 
sodium pyruvate, penicillin/streptomycin (50 units/ml each), 10 mM nicotinamide, 2 
mM L-ascorbic acid phosphate, insulin-transferrin-selenium supplement mixture 
(Gibco), 1×10-7 M dexamethasone, 20 ng/ml HGF, and 10 ng/ml oncostatin M. 
Oncostatin M is dissolved at 10 mg/ml in 0.5% BSA/PBS, and stored at −80 ºC. This 
medium can be preserved at 4 ºC for a month, and should be kept at 37 ºC before use. 
10. Autoclaved nylon meshes with 50 m and 100 m pore size. 
11. 100 mm and 35 mm Petri dishes (BD Biosciences). 
12. 6-well culture plates coated with type I collagen (pre-coated culture plates 
purchased from BD Biosciences). 
13. A water bath at 37 ºC. 
 
2.4. Isolation of murine fetal liver mesenchymal cells using flow cytometry 
1. Solution of 0.25% trypsin-EDTA. 
2. PBS (30 ml) with 3% FBS (1ml) (3%FBS/PBS). 
3. The following antibodies are used: 
Anti-CD45-PE (clone 30-F11, diluted at 1:100, BD Biosciences) 
Anti-CD49f-PE (clone GoH3, 3:100, BD Biosciences)  
Anti-Thy1-FITC (clone 30-H12, 1:100, BD Biosciences)  
Anti-gp38 (Podoplanin, 1:100, Medical and Biological Laboratories, Nagoya, Japan)  
The anti-gp38 antibody is conjugated with APC using a conjugation kit (see Note 8). 
4. 5 ml round-bottom tubes with 35 m nylon meshes. 
5. FACSVantage SE (BD Biosciences). 
6. HD medium (see subheading 2.3.9). 
7. 24-well culture plates coated with type I collagen (pre-coated plates from BD 
Biosciences). 
 
2.5. Co-culture of ESC-derived endodermal cells and murine fetal liver mesenchymal 
cells 
1. A 24-well culture plate coated with type I collagen with murine fetal liver 
mesenchymal cells as a feeder layer. 
2. HD medium (see subheading 2.3.9).
3. Methods 
3.1 Culture of ESC 
Mouse ESCs are cultured in the undifferentiated state on MEF feeder layers (6, 7). They 
are sub-cultured using 0.25% trypsin/EDTA solution. MEFs are prepared according to 
the standard protocols.  
 
3.2. Differentiation of ESCs into endodermal cells 
1. Undifferentiated mouse ESCs that are maintained on 60mm culture dishes are washed 
4 ml PBS twice, added 2ml 0.25% trypsin/EDTA solution at 37 ºC for 2 min, and then 
added 2 ml ESC medium followed by pipetting well to dissociate. They are centrifuged 
at 180 g for 3 min, and resuspended with 4ml ESC medium. In order to deplete MEFs, 
the dissociated cells are transferred onto a plastic culture dish in ESC culture medium, 
and incubated at 37 ºC for 15 to 30 min. 
2. The cell suspension is harvested carefully to avoid removal of the adherent cells and 
centrifuged at 180 g for 3 min. The cell pellet is suspended and plated at a concentration 
of 1 × 10
5
 cells/ml on 60 mm culture dishes coated with type I collagen in SFE medium 
(see Note 9). 
3. 10 M ATRA and 1000 U/ml LIF are added to the SFE medium for the first two days 
(days 0-1), and 20 ng/ml HGF and 20 ng/ml bFGF are added for the next five days 
(days 2-6). Culture medium should be changed every other day at least.  
4. At day 7, the cultured cells are dissociated using a 0.25% trypsin/EDTA solution (do 
as subheading 3.2.1) and re-suspend with HD medium for further experiments (see 
subheading 3.5) (see Note 10). 
 
3.2. Primary culture of murine fetal liver cells 
1. Two timed-pregnant mice are sacrificed according to institutional guidelines. All 
uteri are removed and placed into a 100 mm Petri dish with cold irrigation solution 1. 
Amniotic membranes and placentae are removed, and fetal mice are transferred to a 
new 100 mm Petri dish with cold irrigation solution 1. 
2. The liver tissues are dissected under a stereomicroscope (Fig. 1), and placed into a 
new 100 mm Petri dish with cold irrigation solution 1. The harvested livers are then 
minced into pieces no larger than 1 mm in diameter with a surgical knife. 
3. A nylon mesh (50 m pore size) is placed on a 50 ml centrifuge tube. The minced 
liver tissues are filtered through this mesh. The mesh is inverted and carefully 
transferred onto a new 50 ml centrifuge tube (see Note 11). The flow-through can be 
discarded. 
4. Warm digestion medium (30 ml) is added through the inverted mesh into the 50 ml 
centrifuge tube, collecting the liver tissues into the tube together with the digestion 
medium. The tube is incubated in a water bath at 37 ºC for 12 to 15 min with agitation. 
5. Four nylon meshes (100 m pore size) are placed onto four 15 ml centrifuge tubes. 
The digested tissues are divided into four equal aliquots, filtered through meshes using a 
pipette, collected in the centrifuge tubes, and then centrifuged at 10 g for 5 min (see 
Note 12). 
6. The cell pellet is suspended in 25 ml irrigation solution 2, collected in a 15 ml 
centrifuge tube, and then centrifuged at 10 g for 5 min. This procedure is repeated three 
times in total. 
7. The cell pellet is suspended in HD medium at a density of 5 × 10
5
 cells/ml to 1 × 10
6
 
cells/ml, and inoculated onto 35 mm Petri dishes (see Note 13). 
8. The dissociated cells are incubated at 37 ºC, 5%CO2 overnight. Cell aggregates are 
collected in a 15 ml tube and subjected to gravity sedimentation for 10 min (see Note 
14). 
9. After the supernatant is removed with a pipette, the sedimented cell aggregates are 
suspended in new HD media and plated on 6-well culture plates coated with type I 
collagen (see Note 15).   
10. The cell aggregates are cultured at 37 ºC, 5%CO2 for one to two days. The culture 
media are changed every day. The cell aggregates adhere to the culture plates and grow 
as monolayer colonies.  
  








 mesenchymal cells as a feeder layer 
A key step in this procedure is to obtain a pure and viable cell fraction of the 
mesenchymal cells from murine fetal livers. 
1. Following 1-2 days of culture, the adherent cells are washed twice with 500 l PBS 
and are then incubated with 200 l 0.25% trypsin/EDTA at 37 ºC for 10 min. HD 
medium is added to stop trypsin activity, and all of the cell suspension is collected in a 
15 ml tube.  
2. The collected cells are centrifuged at 180 g for 3 min, and then washed with 5 ml 3% 
FBS/PBS twice by centrifuging at 180 g for 3 min. 
3. The cell pellet is suspended in 200 l 3% FBS/PBS, and transferred into a 1.5 ml tube. 
The dissociated cells are incubated with 2 l CD45-PE (1:100 dilution), 6 l CD49f-PE 
(3:100), 2 l Thy1-FITC (1:100), and 2 l gp38-APC (1:100) antibodies on ice in the 
dark for 30 min. 
4. The cells are centrifuged at 630 g for 2 min, and then the supernatant is discarded.  
5. The cells are washed with 500 l 3% FBS/PBS three times. 
6. The cells are resuspended in 2 to 4 ml 3% FBS/PBS and collected in a 5 ml 









 cell fraction is separated using a FACSVantage SE. 
Dot plots using CD45, CD49f, Thy1, and gp38 antibodies are shown in Fig. 2 (see Note 








 mesenchymal cells are collected in HD 
medium. 
8. The collected cells are suspended in HD medium and seeded in 24-well culture plates 
coated with collagen type I at a density of 1 × 10
4









 mesenchymal cells are grown to approximately 80% 
confluency and treated with 10 g/ml mitomycin C for 2 hours. After washing twice in 
PBS, fresh HD medium is added. The inactivated cells can be used from the next day. 
 
3.5. Maturation of ESC-derived endodermal cells 
1. The dissociated endoderm cells derived from mouse ESCs, generated in section 3.2, 








 mesenchymal cells at a 
density of 1 × 10
4
 cells/well (see Note 18). 









 mesenchymal feeder layer for 7 to 14 days. Culture media 
are changed every day. 
3. These ESC-derived mature hepatocyte-like cells can be used for further analyses 
including drug metabolism and albumin secretion. 
 
4. Notes 
1. In this protocol, a murine ESC line derived from C57BL6 mice are used. The passage 
number is less than 50. Our protocol works with a human ESC line (4).  
2. Because ESC culture medium contains LIF, it should be used within a month. 
3. Culture dishes with a MEF-feeder layer can be used for one week after mitomycin C 
treatment. 
4. Unless stated otherwise, growth factors are added from stock solutions to culture 
medium as required. 
5. The number of pregnant mice can be increased to four mice per experiment. In this 
case, the described protocol can be scaled up. However, it might be technically difficult 
to handle more than five mice at one time since it may be more time-consuming, 
decreasing the viability of harvested liver cells. 
6. Heparin is added in order to prevent clot formation. 
7. DNase is added in order to reduce viscosity caused by DNA that is released from 
damaged cells.  
8. The combination of the fluorescent dyes is actually atypical, because PE labels both 
anti-CD45 and anti-CD49f antibodies. However, as shown in Fig. 2, the CD45-positive 
cell fraction is clearly distinguishable from the CD49f-positive cell fractions based on 
their fluorescent intensities (1). This may result from the difference in the expression 
levels between CD45 and CD49f antigens. 
9. Usually two to four 60 mm collagen type I coated dishes can be harvested from 
undifferentiated ESCs on one confluent 60 mm dish. The concentration of ESCs seeded 
on culture plates is important. Under this condition, differentiating ESCs can be 
cultured for seven days without further passages. During this period, culture medium 
should be changed every other day. 
10. This protocol makes it possible to obtain alpha-fetoprotein (AFP)-producing 
endodermal cells at the efficiency of more than 40% at day 7. However, the optimal 
condition for endodermal differentiation may vary widely with the type of ESCs. For 
example, our recent study revealed that ATRA does not induce hepatic differentiation in 
human ESCs, and that Matrigel (BD Biosciences) is more efficient for hepatic 
differentiation than Type I Collagen (8). Therefore, culture protocols may require 
optimization depending on the ESC lines. 
11. Because fetal livers act as hematopoietic organs during embryonic stages, the 
harvested liver tissues contain a large number of hematopoietic cells. This procedure is 
necessary in order to eliminate hematopoietic cells. The flow-through contains 
hematopoietic cells. 
12. This procedure is performed to eliminate undigested liver tissues. 
13. The harvested liver cells obtained from one pregnant mouse can usually be seeded 
onto three 35 mm Petri dishes, although the yield depends on the number of fetuses. 
14. The cell aggregates can be formed in a few hours. The cell aggregates consist of 
hepatic progenitor cells, hematopoietic cells, and mesenchymal cells. Forming cell 
aggregates can enrich hepatic progenitor cells and mesenchymal cells, and greatly 
facilitate the purification of mesenchymal cells using flow cytometry (9). 
15. The cell aggregates cultured in one 35 mm Petri dish can be usually transferred to 
one well of a 6-well culture plate.  
16. This protocol can be also used to separate hepatic progenitor cells that reside in fetal 






 cell fraction corresponds to hepatic progenitor 






 fraction in 
order to obtain a pure fraction of hepatic progenitor cells. 
17. Cell viability is remarkably decreased at a lower density of cultured cells. 










 mesenchymal cells can be 
isolated from one pregnant mouse. 
18. The ESC-derived endodermal cells consist of not only endodermal cells, but also 
ectodermal and mesodermal cells. Therefore, experimental circumstances may require 
purification of only endodermal cells. In these cases, it may be helpful to generate 
transgenic ESCs that express fluorescent proteins driven by an endoderm-specific gene 
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Figure legends 
Fig. 1 
This photograph shows a mouse fetus after removal of the amniotic membrane and 
placenta. The fetal liver is a red organ located in the middle of a fetus. Under a 
stereomicroscope, the liver is dissected using micro forceps. The gallbladder and 
intestinal tract should be removed from the liver.    
 
Fig. 2 
Dot plots following flow cytometric analyses. (A) Cell aggregates derived from murine 

























 mesenchymal cells are 
further fractionated by gp38 into two groups. The gp38-positive cells account for 






 mesenchymal cells. 
 
Fetal liver 





































Figure 2. T. Ishii et al. 
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